CN Patent

CN103930096A — 用于治疗糖尿病的制剂

Assigned to Xeris Pharmaceuticals Inc · Expires 2014-07-16 · 12y expired

What this patent protects

本发明公开了一种含有胰岛素的用于肠胃外施用的制剂，所述制剂包含在1至4之间或在6至8之间的pH记忆和非质子极性溶剂，其中所述胰岛素溶解于非质子极性溶剂中，其中溶解的胰岛素包括稳定的胰岛素单体或二聚体形式或其混合物，其中所述制剂的水含量等于或小于15％w/v。

USPTO Abstract

本发明公开了一种含有胰岛素的用于肠胃外施用的制剂，所述制剂包含在1至4之间或在6至8之间的pH记忆和非质子极性溶剂，其中所述胰岛素溶解于非质子极性溶剂中，其中溶解的胰岛素包括稳定的胰岛素单体或二聚体形式或其混合物，其中所述制剂的水含量等于或小于15％w/v。

Drugs covered by this patent

Patent Metadata

Patent number
CN103930096A
Jurisdiction
CN
Classification
—
Expires
2014-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Xeris Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.